RxDoctor Payments Data

Karen Cruz

Neurology with Special Qualifications in Child Neurology · Caguas, PRNPI 1952507691

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.

$1,376in general payments, 2019–2025

Across 41 payments — averaging $33.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$243
  • Genentech USA, Inc.$198
  • Lilly USA, LLC$194
  • AbbVie$169
  • Tris Pharma Inc$163
  • PBG Puerto Rico LLC$143
  • plus $266 from 7 others
$653,195in research payments, 2019–2025

Across 121 payments — averaging $5398.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly Export S.A. Puerto Rico Branch$416K
  • AbbVie$137K
  • Eli Lilly$101K

What the payments were for

  • Food & beverage$1,36599%
  • Education$111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,376 in reported general payments places this provider in the 65th percentile of 28 neurology with special qualifications in child neurology providers in Puerto Rico.

See all neurology with special qualifications in child neurology providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam ErLevetiracetam13$289
Topiramate18$225

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →